FDA Rapid Antigen COVID Tests Hold Up After Approval—But Oversight Still Lacking

Retrieved on: 2025-07-23 16:01:07

Tags for this article:

Click the tags to see associated articles and topics

FDA Rapid Antigen COVID Tests Hold Up After Approval—But Oversight Still Lacking. View article details on hiswai:

Excerpt

A new review finds most FDA-authorized COVID-19 rapid antigen tests remain accurate after approval—but 79% lack postmarket evaluation.

Article found on: globalbiodefense.com